Research Article Summary BIOL 501-Senior Project Author, Title, Journal, Year, Volume, Pages 40-Acetoamido-4-hydroxychalcone, a chalcone derivative, inhibits glioma growth and invasion through regulation of the tropomyosin 1 gene Bo Mi Ku a, Hyung Won Ryu b, Yeon Kyung Lee a, Jinhyun Ryu a, Joo Yeon Jeong a, Jungil Choi a, Hee Jun Cho c, Ki Hun Park b,⇑, Sang Soo Kang Key Terms Introduction/ Purpose Research Question/Hypothesis Methods Results Conclusion/Discussion Malignant gliomas are the most common primary malignancies in the brain, and are characterized by widespread invasiveness, angiogenesis, and necrosis Although chemotherapy using temozolomide has recently been shown to improve survival in glioblastoma, the prognosis of gliomas remains very poor. The major reasons for therapeutic failure are the invasiveness and angiogenesis associated with these tumors invading glioma cells or glioma stemcells cause glioma recurrence Therefore, identification of new therapeutic agents that can inhibit glioma invasion and angiogenesis is of great importance and significance Chalcones are considered the precursors of flavonoids that are widely biosynthesized in plants, and possess two aromatic rings joined by a three-carbon a,b-unsaturated carbonyl system 4-hydroxychalcone (AHC), inhibited the invasiveness of glioma cells through regulation of the actin cytoskeleton and suppressed the angiogenic activity of endothelial cells. Moreover, we observed that AHC reduced the growth of human glioma cells inoculated into nude mice. Taken together, our results suggest that AHC might have therapeutic activity against glioma through inhibition of cell invasion and angiogenesis invasion assay transwell migration assay soft agar gel colony formation western blot siRNA infection tube formation assay wound healing assay MTT assay AHC inhibits cell invasion and migration in glioma cell and endothelial cell AHC reduces U87MG cell invasion and migration through expression of tropomyosin PKA activation is required for AHC-mediated tropomyosin expression in U87MG cell 3.4. AHC inhibits glioma cell growth in vivo Here, we show that the synthetic chalcone derivative AHC inhibits glioma cell proliferation, migration, and invasion through regulation of tropomyosin expression. The aim of this study was to identify an effective chalcone derivative that has anti-cancer activity against glioma These data imply that AHC is a potential therapeutic for treatment of glioma and that it is relatively nontoxic to mice we have shown that AHC reduces glioma cell invasion, migration, and growth at a low concentration. We provide evidence that this effect involves, at least in part, regulation of production of the actin binding protein, tropomyosin the synthetic chalcone derivative AHC might be a promising chemotherapeutic agent for gliomas, and that further study of this compound is warranted